Adenosine
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C10H13N5O4 267.24
6-Amino-9-β-D-ribofuranosyl-9H-purine;
9-β-D-Ribofuranosyladenine CAS RN®: 58-61-7; UNII: K72T3FS567.
1 DEFINITION
Adenosine contains NLT 98.0% and NMT 102.0% of adenosine (C10H13N5O4), calculated on the dried basis.
2 IDENTIFICATION
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197M
B. The retention times of the major peaks of the Sample solution correspond to those of the Standard solution, as obtained in the Assay.
3 ASSAY
Change to read:
3.1 Procedure
Buffer: 6.8 g/L of potassium hydrogen sulfate and 3.4 g/L of tetrabutylammonium hydrogen sulfate in a solution prepared as follows. Transfer suitable quantities of potassium hydrogen sulfate and tetrabutylammonium (ERR 1-Oct-2024) hydrogen sulfate to an appropriate volumetric ask, and dissolve in 90% of the ask volume of water. Adjust with 2 N potassium hydroxide to a pH of 6.5, and dilute with water to volume.
Mobile phase: Buffer and water (60:40)
System suitability solution: 4 µg/mL each of USP Adenine RS and inosine in Mobile phase
Standard solution: 0.2 mg/mL of USP Adenosine RS in Mobile phase
Sample solution: 0.2 mg/mL of Adenosine in Mobile phase
3.2 Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Flow rate: 1.5 mL/min
Injection volume: 20 µL
Run time: NLT 1.5 times the retention time of the adenosine peak
3.3 System suitability
Samples: System suitability solution and Standard solution
[Note—See Table 1 for the relative retention times.]
Suitability requirements
Resolution: NLT 1.5 between adenine and inosine, System suitability solution
Tailing factor: NMT 2.0, Standard solution
Relative standard deviation: NMT 0.7%, Standard solution
3.4 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of adenosine (C10H13N5O4) in the portion of Adenosine taken:
Result = (rU /rS ) × (CS /CU) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Adenosine RS in the Standard solution (mg/mL)
CU = concentration of Adenosine in the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
4.1 Organic Impurities
Buffer, Mobile phase, System suitability solution, and Chromatographic system: Proceed as directed in the Assay. Standard solution: 0.001 mg/mL of USP Adenosine RS in Mobile phase
Sample solution: 1 mg/mL of Adenosine in Mobile phase
4.2 System suitability
Samples: System suitability solution and Standard solution
[Note—See Table 1 for the relative retention times.]
4.3 Suitability requirements
Resolution: NLT 1.5 between adenine and inosine, System suitability solution
Relative standard deviation: NMT 5%, Standard solution
4.4 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Adenosine taken:
Result = (rU /rS ) × (CS /CU) × (1/F) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Adenosine RS in the Standard solution (mg/mL)
CU = concentration of Adenosine in the Sample solution (mg/mL)
F = relative response factor (see Table 1)
Acceptance criteria: See Table 1. Disregard peaks that are less than 0.05% of the adenosine peak.
Table 1
Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
Uridine a | 0.29 | 0.73 | 0.10 |
Adenine | 0.34 | 1.6 | 0.2 |
Inosine b | 0.42 | 0.73 | 0.1 |
Guanosine c | 0.51 | 0.86 | 0.10 |
Adenosine | 1.0 | — | — |
Any individual unspecied impurity | — | 1.0 | 0.10 |
Total impurities | — | — | 0.5 |
a 1-β-d-Ribofuranosylpyrimidine-2,4(1H,3H)-dione.
b 9-β-d-Ribofuranosylpurine-6(1H)-one.
c 2-Amino-9-β-d-ribofuranosylpurine-6(1H)-one.
5 SPECIFIC TESTS
Optical Rotation, Specific Rotation 〈781S〉: −68° to −72°
Test solution: 20 mg/mL in sodium hydroxide solution (1 in 20), determined on a sample previously dried at 105° for 2 h
Loss on Drying 〈731〉
Analysis: Dry a sample at 105° for 2 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers, and store at controlled room temperature.
USP Reference Standards 〈11〉
USP Adenine RS
USP Adenosine RS

